Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Receivables - Net (2018 - 2025)

Historic Receivables - Net for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $6.2 million.

  • Dna X's Receivables - Net rose 1839.69% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year increase of 1839.69%. This contributed to the annual value of $6.9 million for FY2024, which is 7299.81% down from last year.
  • According to the latest figures from Q3 2025, Dna X's Receivables - Net is $6.2 million, which was up 1839.69% from $2.9 million recorded in Q2 2025.
  • Dna X's 5-year Receivables - Net high stood at $32.0 million for Q3 2023, and its period low was $2.8 million during Q3 2021.
  • Moreover, its 5-year median value for Receivables - Net was $7.6 million (2025), whereas its average is $13.0 million.
  • Per our database at Business Quant, Dna X's Receivables - Net soared by 48205.86% in 2022 and then plummeted by 8361.37% in 2024.
  • Over the past 5 years, Dna X's Receivables - Net (Quarter) stood at $13.1 million in 2021, then soared by 71.8% to $22.4 million in 2022, then increased by 14.01% to $25.6 million in 2023, then plummeted by 73.0% to $6.9 million in 2024, then fell by 10.17% to $6.2 million in 2025.
  • Its Receivables - Net was $6.2 million in Q3 2025, compared to $2.9 million in Q2 2025 and $7.6 million in Q1 2025.